Journal of Chinese Integrative Medicine ›› 2009, Vol. 7 ›› Issue (7): 622-628.doi: 10.3736/jcim20090705
• Original Clinical Research • Previous Articles Next Articles
Therapeutic effects of modified Danggui Sini Decoction on plasma level of advanced glycation end products in patients with Wagner grade 0 diabetic foot: A randomized controlled trial
Wei-hua Youa,Ping Wangb,Mao-qing Lib,Yu Zhangc
,Yu-lan Pengd,Feng-ling Zhange
- a Department of Internal Medicine, Maoming Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine,Maoming 525000,Guangdong Province,China
b First Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong Province, China
c Department of Ultrasound, Maoming Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Maoming 525000,Guangdong Province,China
d School of Traditional Chinese Medicine, Changsha Medical University, Changsha 420219, Hunan Province, China
e Department of Electrocardiography, Nanning Second People’ s Hospital,Nanning 530031,Guangxi Zhuang Autonomous Region, China;
| [1] |
Boulton AJ . The diabetic foot: a global view[J]. Diabetes Metab Res Rev, 2000,16(1):S2-S5
doi: 10.1002/(ISSN)1520-7560 |
| [2] |
Fryberg RG . Diabetic foot ulcerations: management and adjunctive therapy[J]. Clin Podiatr Med Surg, 2003,20(4):709-728
doi: 10.1016/S0891-8422(03)00069-7 pmid: 14636034 |
| [3] | Zeng WH, Lai GM, Gan EH . Analysis of risk factors for diabetes foot amputation[J]. Zhongguo Tang Niao Bing Za Zi, 2002,10(4):252-253 |
| 曾文和, 赖国民, 甘尔惠 . 糖尿病足截肢危险因素分析[J]. 中国糖尿病杂志, 2002,10(4):252-253 | |
| [4] | Jensen LJ, Stergaard J, Flyvbjerg A . AGE-RAGE and AGE cross-link interaction: important players in the pathogenesis of diabetic kidney disease[J]. Horm Metab Res, 2005,37(1):26-34 |
| [5] | State Administration of Traditional Chinese Medicine. Diagnostic and therapeutic effect evaluation criteria of diseases and syndromes in traditional Chinese medicine[M]. Nanjing: Nanjing University Press, 1994: 59-60 |
| 国家中医药管理局. 中医病证诊断疗效标准[M]. 南京: 南京大学出版社, 1994: 59-60 | |
| [6] | World Health Organization . Definition, diagnosis and classification of diabetes mellitus and its complication, report of a WHO consultation. 1999: 1 |
| [7] | Li SM. Diagnosis and treatment of diabetic foot and its complication[M]. Beijing: People’s Medical Publishing House, 2002: 168-169 |
| 李仕明 . 糖尿病足与相关并发症的诊治[M]. 北京: 人民卫生出版社, 2002: 168-169 | |
| [8] |
Xue ZR . Classification of diabetic foot and progress of diagnosis and treatment[J]. Nei Ke Ji Wei Zhong Zheng Za Zi, 2002,8(1):32-35
doi: 10.3969/j.issn.1007-1024.2002.01.014 |
|
许樟荣 . 糖尿病足病变的分类与诊治进展[J]. 内科急危重症杂志, 2002,8(1):32-35
doi: 10.3969/j.issn.1007-1024.2002.01.014 |
|
| [9] |
Basta G, Schmidt AM, De Caterina R . Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes[J]. Cardiovasc Res, 2004,63(4):582-592
doi: 10.1016/j.cardiores.2004.05.001 |
| [10] |
Enomoto M, Adachi H, Yamagishi S, Takeuchi M, Furuki K, Hino A, Hiratsuka A, Takajo Y, Imaizumi T . Positive association of serum levels of advanced glycation end products with thrombogenic markers in humans[J]. Metabolism, 2006,55(7):912-917
doi: 10.1016/j.metabol.2006.02.019 |
| [11] |
Forbes JM, Yee LT, Thallas V, Lassila M, Candido R, Jandeleit-Dahm KA, Thomas MC, Burns WC, Deemer EK, Thorpe SR, Cooper ME, Allen TJ . Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis[J]. Diabetes, 2004,53(7):1813-1823
doi: 10.2337/diabetes.53.7.1813 pmid: 15220206 |
| [12] | Basta G, Lazzerini G, Del Turco S, Ratto GM, Schmidt AM, De Caterina R . At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products[J]. Arterioscler Thromb Vasc Biol, 2005,25(7):1404-1407 |
| [13] |
Frank GD, Eguchi S, Motley ED . The role of reactive oxygen species in insulin signaling in the vasculature[J]. Antioxid Redox Signal, 2005,7(7-8):1053-1061
doi: 10.1089/ars.2005.7.1053 pmid: 15998260 |
| [14] | Chang Z, Lu Y . Filtering the active ingredients of Chinese medicine with AGEs platform[J]. Nanjing Zhong Yi Yao Da Xue Xue Bao, 2004,20(3):167-168 |
| 常在, 陆茵 . AGEs平台筛选中药及中药有效成分[J]. 南京中医药大学学报, 2004,20(3):167-168 | |
| [15] |
Xu HQ, Zhu Q, Li X, Zhang AH, Guo R . Inhibition of non-enzymic advanced glycation end products(AGEs) in vitro by seven TCMs[J]. Zhong Cao Yao, 2002,33(2):145-147
doi: 10.3321/j.issn:0253-2670.2002.02.024 |
|
许惠琴, 朱荃, 李祥, 张爱华, 郭戎 . 7味中药对体外非酶糖化终产物生成的抑制作用[J]. 中草药, 2002,33(2):145-147
doi: 10.3321/j.issn:0253-2670.2002.02.024 |
|
| [16] | Wang YJ, Wang XK, Chen LP . Effects of Danggui Sini Decoction and Lulutong Injection on treating diabetes leg arteriosclerosis obliterans[J]. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zi, 2004,10(1):60-62 |
| 汪艳娟, 王行宽, 陈丽萍 . 当归四逆汤合路路通注射液治疗糖尿病下肢动脉硬化闭塞症的临床观察[J]. 中国中医基础医学杂志, 2004,10(1):60-62 |